Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Carbamazepine‐hypersensitivity: assessment of clinical and in vitro chemical cross‐reactivity with phenytoin and oxcarbazepine.
1991
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
1992
Emerging organic contaminants in groundwater: A review of sources, fate and occurrence
2012 Standout
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
2011
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Oral Anticoagulant Therapy
2012 Standout
Cytochrome P450-mediated metabolism in the human gut wall
2009
Glioblastoma and Other Malignant Gliomas
2013 Standout
Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks
2012
VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
2004
Drug-Induced Hepatotoxicity
2003 Standout
pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A
2004
Adverse Drug Interactions in Anesthesia
1997
A Pharmacokinetic Study of Intravenous Itraconazole Followed by Oral Administration of Itraconazole Capsules in Patients with Advanced Human Immunodeficiency Virus Infection
1998
Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation*
1996
Solid lipid nanoparticles Production, characterization and applications
2001 Standout
Clinically relevant drug interactions with antiepileptic drugs
2005
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Comparative Pharmacology of Newer Progestogens
1996
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Targeting multidrug resistance in cancer
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
2004
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Polycystic Ovary Syndrome
2005 Standout
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
2012
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
1998
Oral Azole Drugs as Systemic Antifungal Therapy
1994
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone
2007
Antifungal agents: An overview. Part II
1994
Drug interaction studies between paclitaxel (Taxol) and OC144-093 — A new modulator of MDR in cancer chemotherapy
2002
Pharmacology of estrogens and progestogens: influence of different routes of administration
2005
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Herbal Medicines and Perioperative Care
2001 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Antipyrine as a model drug to study hepatic drug-metabolizing capacity
1988
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Itraconazole Affects Single‐Dose Terfenadine Pharmacokinetics and Cardiac Repolarization Pharmacodynamics
1993
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450
2000
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
2011
A Mechanistic Approach to Antiepileptic Drug Interactions
1998
Drug−Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development
2003
Tumour stem cells and drug resistance
2005 Standout
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Clinical significance of the sparteine/debrisoquine oxidation polymorphism
1989
Transport, metabolism and elimination mechanisms of anti-HIV agents
1999
Worldwide Variation in Human Drug-Metabolism Enzyme GenesCYP2B6andUGT2B7: Implications for HIV/AIDS Treatment
2012
Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves
2010 StandoutNobel
Current and Emerging Azole Antifungal Agents
1999 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial
2003
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
The Many Roles for Fluorine in Medicinal Chemistry
2008 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Metabolism-guided drug design
2012
Drug Therapy in the Heart Transplant Recipient
2005
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Cytochrome P450-mediated metabolism in the human gut wall
2009
Direct and metabolism‐dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.
1991
Prophylactic Fluconazole in Liver Transplant Recipients
1999
Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism
1997
Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease
1995
Solid lipid nanoparticles as drug carriers
1998
Systemic Antifungal Agents
1998
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Occurrence and Fate of Estrone, 17β-estradiol and 17α-ethynylestradiol in STPs for Domestic Wastewater
2005
Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients1
2002
Metal–Organic Frameworks in Biomedicine
2011 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
2006 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium
1997
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
2011
Coronavirus Infections—More Than Just the Common Cold
2020 Standout
Macrolide Antibacterials
1995
Works of DJ Back being referenced
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy
2010
Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.
1989
Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
2009
The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC
2009
The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.
1990
Cyclosporin metabolism by human gastrointestinal mucosal microsomes.
1992
2‐Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine.
1984
Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women.
1988
Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.
1994
Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa.
1989
Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive‐drug interactions with anticonvulsants and antibiotics.
1988
Azoles and allylamines: the clinical implications of interaction with cytochrome P-450 enzymes
1990
Effect of chloroquine and primaquine on antipyrine metabolism.
1983
Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomes.
1989
Extrahepatic metabolism of zidovudine.
1992
The metabolism of 17 alpha‐ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.
1987
The effects of ampicillin oral contraceptive steroids in women.
1982
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.
1988
Tolbutamide 4‐hydroxylase activity of human liver microsomes: effect of inhibitors.
1987
Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
1991
The gut wall metabolism of ethinyloestradiol and its contribution to the pre‐systemic metabolism of ethinyloestradiol in humans.
1982
Cyclosporin metabolism by the gastrointestinal mucosa.
1991